Warum Wissenschaftler sich auf CBD-Forschung konzentrieren-Eco-Cannabis.eu

Why scientists are focusing on CBD research

Why scientists are focusing on CBD research
Researchers are scientists focused on studying CBD at the molecular level. A large budget has been expended on research in the last two decades. There are so many aspects that have been researched successfully and the results of this research have led to the CBD drug development process.

Scientists have reported that the hemp plant contains a large number of naturally occurring active cannabinoids such as cannabidiol (CBD) as well as the formerly better known tetrahydrocannabinol (THC). CBD does not contain any of the medicinal properties of sister chemical THC and does not cause chills or intoxication. Thus, it is the perfect basis for a new age of medicines and treatments.

CBD Research Findings

Its potential antifungal, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-inflammatory and anti-cancer properties are researched and researched daily around the world, making it a perfect and organic active chemical for cosmetics and medicines.

Studies published by the Federation of American Societies for Experimental Studies have also shown that cannabinoids are responsible for the formation of lipids and therefore play an important role in regulating and healing skin diseases. Additionally, these remedial actions are highly effective when implemented independently and locally.

Evidence-Based Research

CBD also serves to increase the rate of absorption of various chemicals for the skin, so CBD due to its properties in topical cosmetic software leads to a healthy, safe and nourishing epidermis and forms the perfect foundation for a new age of groundbreaking, compelling, cosmetic remedies.

Additionally, reviewing numerous research studies on the effectiveness and safety of CBD in a variety of dosages, such as B. severe and chronic dosages, no significant side effects were found in various treatment methods. The minimal effect of THC is due to the stimulation of the CB1 receptors. CBD has a fairly low affinity for these receptors and when it binds it produces little to no result. There is also growing evidence that CBD behaves in additional brain signaling methods that may make significant contributions to therapeutic outcomes.

The clinical trials are still needed to evaluate the clinical possibility of CBD in getting certain conditions. However, pre-clinical study (such as both cell culture and animal models) has found that CBD exhibits a selection of consequences that could be therapeutically beneficial such as antimicrobial, antioxidant, neuroprotective, anti-inflammatory, analgesic and anti-inflammatory properties.

References:

1. Stahl RW, Miller JH, Sim DA, Tag DJ. Delta-9-tetrahydrocannabinol disrupts hippocampal neuroplasticity and neurogenesis in trained but not untrained juvenile Sprague-Dawley rats. Brain Res. 2014 Feb 22; 1548:12-9.
2. Kalant, H. Effects of cannabis and cannabinoids on the human nervous system, Effects of drugs on the human nervous system, BK Madras and MJ Kuhar eds, Elsevier 2014, ISBN: 978-0-12-418679-8.
3. Wittling PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J. Cannabinoids for medicinal purposes: A systematic review and meta-analysis. JAMA. 2015 June 23-30; 313 (24): 2456 - 73
4. Lazary J, Juhasz G, Hunyady L, Bagdy G. Personalized medicines may pave the way for the safe use of CB1; -Pave receptor antagonists. Trends Pharmacol Sci. 2011 May; 32(5): 270-270 80
Back to blog